Hepatocellular Carcinoma

Showing NaN - NaN of 78

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatocellular Carcinoma Trial in Taipei (Statin and Metformin use)

Terminated
  • Hepatocellular Carcinoma
  • Statin and Metformin use
  • Taipei, Taiwan
    Taipei Medical University - WanFang Hospital
Apr 18, 2017

Hepatocellular Carcinoma Trial in Worldwide (Patupilone)

Completed
  • Hepatocellular Carcinoma
  • San Francisco, California
  • +6 more
Feb 3, 2017

Hepatocellular Carcinoma Trial in Worldwide (Placebo, Ramucirumab DP (IMC-1121B), BSC)

Completed
  • Hepatocellular Carcinoma
  • Placebo
  • +2 more
  • Orange, California
  • +145 more
Nov 24, 2015

Hepatocellular Carcinoma Trial in Worldwide (dovitinib, sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Nanjing, Jiangsu, China
  • +23 more
Nov 2, 2015

Hepatocellular Carcinoma Trial in Taipei (Cefazolin)

Unknown status
  • Hepatocellular Carcinoma
  • Taipei, Taiwan
    Division of Gastroenterology, Department of Medicine, Taipei Vet
Aug 25, 2015

Hepatocellular Carcinoma Trial in Taiwan, United States (GC33(RO5137382), Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • San Francisco, California
  • +6 more
Oct 1, 2014

PLA for HCC and Esophageal ca Serum

Unknown status
  • Hepatocellular Carcinoma
  • Esophageal Cancer
    • Taipei, Taiwan
      National Taiwan University Hospital
    Apr 15, 2014

    Hepatocellular Carcinoma, Liver Disease Trial in Taipei (18F- fluorocholine, 18F- fluorodeoxyglucose)

    Unknown status
    • Hepatocellular Carcinoma
    • Liver Disease
    • 18F- fluorocholine
    • 18F- fluorodeoxyglucose
    • Taipei, Taiwan
      National Taiwan University Hospital
    Feb 27, 2014

    Hepatocellular Carcinoma Trial in Worldwide (BIIB022, Sorafenib)

    Completed
    • Hepatocellular Carcinoma
    • Denver, Colorado
    • +10 more
    Sep 12, 2013

    Hepatocellular Carcinoma Trial in Worldwide (PR104 550 mg/m^2 + sorafenib, PR104 770 mg/m^2 + sorafenib)

    Terminated
    • Hepatocellular Carcinoma
    • PR104 550 mg/m^2 + sorafenib
    • PR104 770 mg/m^2 + sorafenib
    • Tucson, Arizona
    • +16 more
    Jul 19, 2013

    Hepatocellular Carcinoma Trial in Taipei (Thalidomide, Tegafur/Uracil)

    Completed
    • Hepatocellular Carcinoma
    • Taipei, Taiwan
      Department of Oncology , National Taiwan University Hospital
    Oct 13, 2011

    Hepatocellular Carcinoma Trial in Orange, Shatin, New Territories, Taipei (MB07133 300mg/m2/day, MB07133 600 mg/m2/day, MB07133

    Completed
    • Hepatocellular Carcinoma
    • MB07133 300mg/m2/day
    • +4 more
    • Orange, California
    • +3 more
    Aug 10, 2011

    Combined Sorafenib With Radiotherapy in Advanced Hepatocellular

    Unknown status
    • Hepatocellular Carcinoma
    • sorafenib and radiotherapy for hepatocellular carcinoma
    • Taichung, Taiwan
    • +2 more
    Apr 1, 2011

    Combined Radiotherapy and Sorafenib in Patients With Hepatoma

    Unknown status
    • Hepatocellular Carcinoma
    • Radiotherapy combined with sorafenib
    • Tainan, Taiwan
    • +1 more
    Mar 21, 2011

    Dynamic Contrast-enhanced Magnetic Resonance Imaging in

    Unknown status
    • Hepatocellular Carcinoma
      • Taipei, Taiwan
        National Taiwan University Hospital
      Jan 20, 2011

      Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma

      Unknown status
      • Chronic Hepatitis B
      • Hepatocellular Carcinoma
      • Taipei, Taiwan
        Department of Medicine, Taipei Veterans General Hospital
      Jan 4, 2011

      Hepatocellular Carcinoma Trial in Taiwan (doxorubicin, TACE (Transcatheter arterial chemoembolization))

      Unknown status
      • Hepatocellular Carcinoma
      • doxorubicin
      • TACE (Transcatheter arterial chemoembolization)
      • Kaohsiung, Taiwan
      • +7 more
      Jan 3, 2011

      Associated With Hepatic Carcinogenesis

      Unknown status
      • Hepatocellular Carcinoma
        • Taipei, Taiwan
          National Taiwan University Hospital
        Nov 22, 2010

        Hepatocellular Carcinoma Trial in Taipei (3DCRT or IMRT)

        Unknown status
        • Hepatocellular Carcinoma
        • 3DCRT or IMRT
        • Taipei, Taiwan
          National Taiwan University Hospital
        Oct 13, 2009

        Hepatocellular Carcinoma Trial in Taipei (Sorafenib, tegafur/uracil (UFUR®))

        Completed
        • Hepatocellular Carcinoma
        • Taipei, Taiwan
          National Taiwan University Hospital
        Jul 6, 2009

        Hepatocellular Carcinoma Trial in Tainan, Taipei (RAD001 (everolimus))

        Unknown status
        • Hepatocellular Carcinoma
        • RAD001 (everolimus)
        • Tainan, Taiwan
        • +1 more
        Jun 29, 2009

        Hepatocellular Carcinoma Trial in Singapore, Taiwan, United States (ADH300004)

        Terminated
        • Hepatocellular Carcinoma
        • Honolulu, Hawaii
        • +6 more
        Dec 12, 2008

        Hepatocellular Carcinoma, Liver Cancer Trial in Taiwan, United States (PHY906, capecitabine)

        Completed
        • Hepatocellular Carcinoma
        • Liver Cancer
        • Duarte, California
        • +4 more
        Mar 27, 2007

        Associated With Human Hepatocellular Carcinoma by SELDI

        Unknown status
        • Hepatocellular Carcinoma
        • +2 more
          • Taipei, Taiwan
            National Taiwan University Hospital
          Dec 19, 2005

          Searching for the Liver Cancer-Related Biomarkers

          Unknown status
          • Hepatocellular Carcinoma
            • Taipei, Taiwan
              National Taiwan University Hospital
            Dec 19, 2005